Traditional Uses, Chemical Constituents and Biological Activities of Plants from the Genus Sanguisorba L.

Authors Zhao, Zefeng; He, Xirui; Zhang, Qiang; Wei, Xiaoyang; Huang, Linhong; Fang, Jia Cheng; Wang, Xiaoxiao; Zhao, Meimei; Bai, Yajun; Zheng, Xiaohui

Journal AMERICAN JOURNAL OF CHINESE MEDICINE , 2017,2:45

DOI 10.1142/S0192415X17500136 PubMed 28249548

Abstract Plants from the genus Sanguisorba have been treated as medicinal ingredients for over 2000 years. This paper reviews advances in the botanical, phytochemical and pharmacological studies of the genus. To date, more than 120 chemical constituents have been isolated and identified from these plants, especially from S. officinalis and S. minor. Among these compounds, triterpenoids, phenols and flavonoids are the primary biologically active constituents. Triterpenoids can be used as quality control markers to determine the quality of medicinal materials and their preparations. In vivo and in vitro studies have shown that plants from the genus Sanguisorba exhibit a wide range of pharmacological properties, including hemostatic, antibacterial, antitumor, neuroprotective and hypoglycemic activities. In Chinese medical practice, many drugs (e.g., tablets and powders) that contain S. officinalis roots have been used to treat leukopenia, hemorrhaging and burns. However, there is still a multitude of Sanguisorba species that have garnered little or no attention. Indeed, there are few reports concerning the clinical use and toxic effects of these plants. Further attention should be focused on the study of these species in order to gather information on their respective toxicology data, any relevant quality-control measures, and the clinical value of the crude extracts, active compounds, and bioactive metabolites from Genus Sanguisorba.